Oversea-Chinese Banking Corp (OCBC)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
45,483
+5,386
+13% +$231K 0.05% 193
2026
Q1
$1.45M Sell
40,097
-19,347
-33% -$917K 0.04% 193
2025
Q4
$3.06M Buy
59,444
+45,785
+335% +$2.34M 0.08% 141
2025
Q3
$759K Sell
13,659
-3,872
-22% -$227K 0.02% 232
2025
Q2
$1.19M Sell
17,531
-11,949
-41% -$813K 0.03% 197
2025
Q1
$2.06M Buy
29,480
+9,104
+45% +$752K 0.06% 173
2024
Q4
$1.77M Buy
20,376
+10,101
+98% +$1.09M 0.05% 180
2024
Q3
$1.24M Buy
10,275
+3,762
+58% +$502K 0.03% 216
2024
Q2
$930K Sell
6,513
-510
-7% -$67.6K 0.03% 229
2024
Q1
$902K Buy
+7,023
New +$836K 0.03% 230

Other funds holding NVO

Oversea-Chinese Banking Corp (OCBC)'s NVO Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $231K and bringing the position to 45,483 shares worth $2.19M. The position accounts for 0.05% of the portfolio, ranked #193.

Oversea-Chinese Banking Corp (OCBC) first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.06M in Q4 2025. 960 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 45,483 shares of Novo Nordisk worth $2.19M as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) bought 5,386 Novo Nordisk shares in Q2 2026, an estimated $231K.
  • Novo Nordisk made up 0.05% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #193 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Novo Nordisk position peaked at $3.06M in Q4 2025.
  • 960 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.